Midgard Science

Labs / ADME, DMPK & toxicology

Tubulis

Planegg-Martinsried, Germany · tubulis.com

GLP · GMP

On your own

Free. Their own form.

Contact Tubulis directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Tubulis develops next-generation antibody-drug conjugates and related conjugation technologies for oncology. The company is based in Munich, with additional locations in Cambridge, Massachusetts, and Epalinges, Switzerland, and its programs include clinical-stage candidates for solid tumors and hematologic tumors.

They take quote requests by email.

What they offer

  • ADC technology platforms

    Develops platform technologies for antibody-drug conjugates, including P5 Conjugation, Tubutecan, and Alco5.

  • ADC candidate development

    Develops antibody-drug conjugate candidates such as TUB-040 and TUB-030 for oncology indications.

  • Protein-drug conjugate expertise

    Offers its conjugation technology and expertise for uniquely matched protein-drug conjugates.

What they work on

Modalities
Small molecule, Antibody, Bispecific, ADC, Cell therapy
Species and models
preclinical models, solid tumors, hematologic tumors
Therapeutic areas
oncology, ovarian cancer, non-small cell lung cancer, solid tumors, hematologic tumors
Sites
Planegg-Martinsried, Germany · Cambridge, United States · Epalinges, Switzerland
Quality
GxP (quality management and compliance management)
Address
1066 Epalinges The Tubulis Team Dr. Dominik Schumacher CEO View BIO CV of Dr. Dominik Schumacher Dominik
Founded
2015

Public records

Ownership
Tubulis GmbH · DE GLEIF

Similar labs. Evotec, Bambusa Therapeutics, ProtaGene, Sai Life

Found in a contract services directory. Listing built from tubulis.com. Work here? Claim this listing.

Tubulis · Midgard Science